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Introduction
Erectile dysfunction (ED) is defined as the “inability to attain 
or maintain penile erection sufficient for satisfactory sexual 
performance”.1 The prevalence of ED is increasing, and it is 
estimated that 322 million men worldwide will be affected 
by 2025, with the largest projected increase occurring in 
developing countries.2 The prevalence of ED varies from 
6.4-70.1%, and the wide variation is mainly due to the 
difference in assessment tools used, and the populations 
studied.3-8
Physiologically, normal erection is maintained by a complex 
interplay between vascular and neurological events. Any 
condition that affects the vascular supply or the neuronal 
pathways to the penis, whether medical or psychological 
in origin, may cause ED.1,9,10 Studies have shown that the 
prevalence of ED is significantly associated with age, the 
presence of co-morbid conditions and smoking.3,4,6 Millions 
of men are affected by ED, often suffering in silence, while 
experiencing significant mental and psychological stress 
that affects their familial relationships and their social lives. 
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Background: Erectile dysfunction (ED) is common amongst hypertensive men. Hypertensive patients often attribute 
it to antihypertensive drugs, although conflicting evidence linking ED with antihypertensive medication exists. 
The objectives were to determine the prevalence and severity of ED, the type of treatment sought, and the risk factors for 
ED among hypertensive men.
Method: A cross-sectional survey conducted over six months from June to November 2008 at University Kebangsaan, 
Malaysia Medical Centre, Kuala Lumpur. Inclusion criteria included hypertensive men above 30 years old, with essential 
hypertension for at least three months. We excluded diabetics, a history of pelvic surgery and known psychiatric illnesses. 
The International Index of Erectile Function-5 (IIEF-5) assessment was used with a standardised checklist. We analysed 
data using SPSS, to assess the prevalence and association of ED with selected variables.
Results: Of the 200 participants screened, 35.5% perceived that they had ED. However, prevalence increased 
to 69% after screening using an IIEF-5 questionnaire. Forty-eight per cent were reported to have moderate-to-
severe ED. ED was significantly associated with age (p-value = 0.0001). No significant associations were found 
between ED and the duration of the hypertension (p-value = 0.505), hypertension control (p-value > 0.05), smoking 
status (p-value = 0.858) or number of antihypertensive medication taken (p-value > 0.05). Among perceived 
and proven ED patients, traditional medicines were mainly used for treatment (18.3% and 17.2% respectively). 
Conclusion: ED is a problem among hypertensive patients. It was associated with age but not with hypertension duration, 
control, number of antihypertensive drugs or smoking. Physicians should enquire about ED symptoms in hypertensive 
patients, as most of them resorted to self-treatment with traditional medicines.
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Current research on ED focuses on the high prevalence 
among men who have cardiovascular disease.11 
Hypertension is an important risk factor for ED.1,3,4 
Emphasising the correlation between ED and hypertension 
allowed for opportunistic screening, i.e. cardiovascular risk 
assessment, of this problem, which would have not been 
addressed voluntarily by patients with ED symptoms.11
To date, there have been few studies that have actively 
screened for and detected the presence of ED among 
hypertensive patients. With the rise in prevalence of 
hypertension, the burden of illness and treatment costs 
pose problems in terms of long-term healthcare planning 
and budgeting. The wide range of options available for ED 
treatment allows for early and appropriate intervention to 
improve the quality of life of these men. Our study aims 
to determine the prevalence of ED among hypertensive 
patients, and the factors associated with this condition.
Method
A cross-sectional study was conducted at the University 
Kebangsaan Malaysia Medical Centre (UKMMC) in Kuala 
Lumpur, Malaysia, for a period of six months, from June-
November 2008. A total of 200 male hypertensive patients 
aged 30 and above, attending the UKM Primary Care Centre 
and the medical outpatient clinic at UKMMC, were recruited 
during the study period. There was a 100% response rate. 
Patients with concomitant diabetes mellitus, a previous 
history of pelvic surgery and psychiatric illness were 
excluded because these conditions are associated with ED.
Two sets of questionnaires were used in this study. The first 
consisted of a checklist on demographic data, hypertensive 
profiles and other cardiovascular risk factors. In this 
questionnaire, the patients’ perceptions of having ED were 
assessed in a “yes” or “no” format. Information regarding 
intervention, or on remedies taken for the perceived 
condition, was also recorded. This included either drugs, 
or traditional remedies, used in the preceding six months.
The second questionnaire was the International Index of 
Erectile Function-5 (IIEF-5), an abbreviated version of the 
International Index of Erectile Function (IIEF). This was 
used to assess the level of ED. The original IIEF contains 
15 items that evaluate five distinct domains of male sexual 
function: erectile functionality (questions 1, 2, 3, 4, 5 and 
15), orgasmic function (questions 9 and 10), sexual desire 
(questions 11 and 12), intercourse satisfaction (questions 6, 
7 and 8), and overall satisfaction (questions 13 and 14). The 
IIEF-5 contains only five of the original 15 questions, namely 
questions 2, 4, 5, 7 and 15. Each question has five different 
answer options that carry marks of 0-5, bringing the total 
score to 25 points. Scores for ED severity are categorised as 
none (score 22-25), mild ED (score 17-21), mild-to-moderate 
ED (score 12-16), moderate ED (score 8-11) and severe ED 
(score 1-7). A validated Malay-version IIEF-5 questionnaire 
was used concurrently.12 Missing or incomplete data on the 
patients’ clinical profiles and recent special investigation 
results were extracted from the patients’ medical records.
Ethical approval was obtained from the medical and ethics 
committee of the UKMMC. Informed consent was obtained 
by the researcher after the participants fully understood 
the aims and the nature of the study. All interviews were 
conducted privately by the researcher herself. The 
confidentiality and anonymity of the participants were 
maintained throughout the study. Data extracted from the 
patients’ medical records were computerised, and were 
not linked to any identifying information. The data were 
kept in electronic copy form, and were only accessible by 
the researcher. Access to identification information was 
restricted to the researcher and the study coordinator. All the 
participants received standard care for their hypertension. 
Those identified as having ED were appropriately treated 
and/or referred.
Statistical analysis
Data were analysed using SPSS (Statistical Program for 
Social Sciences) software, version 12.0.1. Pearson’s chi-
square was used to determine the association between 
two categorical variables. Student’s t-test and analysis 
of variance (ANOVA) were used to determine significant 
differences between the means of two or more groups. All 
tests were carried out using a priori level of significance of 
0.05.
Results 
Demographic and clinical characteristics
The socio-demographic characteristics of the participants 
are recorded in Table I. 
The mean age of the participants was 58.4  ±  8.9 years 
(range 37-80 years), with 75% in the 51-70-year-age group. 
The mean blood pressure was 136.0 ± 15.9 mmHg systolic, 
and 80.9 ± 9.9 mmHg diastolic. Regarding blood pressure 
control, 52% had systolic readings of less than 140 mmHg, 
and 75% recorded a diastolic pressure of less than 90 
mmHg. 
The mean total cholesterol level was 5.23 ± 0.98 mmol/l, 
the mean low-density lipoprotein (LDL) cholesterol was 3.14 
± 0.84 mmol/l, and the mean high-density lipoprotein (HDL) 
cholesterol was 1.36 ± 0.36 mmol/l.
Prevalence of actual and perceived erectile dysfunction
The prevalence and severity of ED based on the IIEF-5 
scores are listed in Tables II and III. 
Our study demonstrated that 35.5% (71/200) of the 
participants perceived that they had ED. However, 69% 
(138/200) of the same cohort had actual ED based on the 
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IIEF-5 score. The overall degree of ED severity was severe 
(34%), moderate (1%), mild to moderate (13%) and mild 
(21%). The remaining 31% did not have any ED. 
In terms of perception and having actual ED, 57.4% (74/138) 
who perceived themselves as “normal” had proven ED 
based on the IIEF-5 scores. A highly statistical significant 
association was found between the perception of having ED 
and proven ED based on the IIEF-5 scores (χ2 = 23, df = 1, 
p-value = 0.0001).
Treatments taken for ED
Our study showed that slightly more than two-thirds of 
the patients proven to have ED did not seek any form of 
treatment for their condition. The details of the types of 
treatment taken for either perceived, or actual, ED are listed 
in Table IV. 
Erectile dysfunction and associated factors
Our study demonstrated that there was a significant 
association between ED and the age of the respondents 
(p-value  <  0.05) (Table V), although the number of 
antihypertensive medications taken was not associated 
with the presence of ED (χ2 = 0.253, df = 2, p-value = 0.881) 
(Table VI). There was no significant association between 
ED and total cholesterol and HDL cholesterol control 
levels. A post hoc test was carried out to further analyse 
the association between LDL cholesterol control and ED 
(Table IV). Taken together, the results suggest that LDL 
cholesterol control levels do not have an effect on ED.













Ex-smoker (stopped ≤ three months) 72 (36.0)
Current smoker 29 (14.5)
Types of antihypertensive medications
Beta blockers 87 (43.5)
Diuretics 77 (38.5)
Calcium-channel blockers 79 (39.5)
Angiotensin-converting enzyme inhibitors 32 (16.0)
Alpha blockers 3 (1.5)
Table II: ED prevalence among hypertensive patients: perception of 






Yes 64 (90.1) 7 (9.9) 71 χ2 = 23.00
df = 1
p = 0.0001
No 74 (57.4) 55 (42.6) 129
Total 138 62 200
Table III: ED prevalence among hypertensive patients: perception of having ED and proven ED by severity group
Perception Severity of ED n (%)
Severe Moderate Mild to 
moderate
Mild No ED Total Pearson’s χ2
Yes 29 (40.8) 2 (2.8) 16 (22.5) 17 (23.9) 7 (9.9) 71 χ2=29.174
df=4
p = 0.0001
No 39 (30.2) 0 (0.0) 10 (7.8) 25 (19.4) 55 (42.6) 129
Table IV: Treatment taken by patients with perceived and proven ED












Yes 8 (11.3) 13 (18.3) 5 (7.1) 45 (63.4) 71 (35.5)
No - - - - 129 (64.5)
Total 200 (100.0)
aProven ED
Yes 5 (7.8) 11 (17.2) 5 (7.8) 43 (67.3) 64 (100.0)
No 2 (28.6) 2 (28.6) 0 3 (42.9) 7 (100.0)
a = χ2 = 7.142, df = 3, p-value = 0.068
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Discussion 
Our study demonstrated that many Malaysian men with 
hypertension are unaware that they might have ED. This 
illustrates the enormous extent of the problem. In our study, 
only one in two respondents realised that they were suffering 
from varying degrees of ED. It also demonstrated that 
participants with perceived ED, and those with actual ED, 
resorted to traditional remedies to resolve their problems.
The significant difference in the prevalence of perceived and 
actual ED might be due to Asian values, and community 
perception of this condition. Studies have shown that Asian 
men are sexually conservative, and that their perception 
of and attitude towards ED influences their willingness to 
report and discuss it.7,13,14 In a study by Doumas et al on 
hypertensive Greek patients residing in the Mediterranean 
area, a similar observation was made, as erectile functionality 
was considered to be a matter of honour, and was not easily 
discussed with a doctor.15 This may suggest that ED is still 
considered by men to be a private matter .
We hypothesise that there is a possibility that patients with 
ED might openly approach their doctors to discuss their 
condition. Their partners’ sexual dissatisfaction and needs 
would prompt these men to seek medical help,16 and if these 
issues were not addressed by the couple, it may be unlikely 
that ED is perceived to be a problem. From the literature, 
we also note that Malaysian men are more likely to discuss 
their ED problem with a friend or relative, prior to seeing a 
doctor.6 Problems would arise if this person were unreliable 
and provided information that could result in complications, 
for example drug-related interactions or toxicity.
A qualitative study by Low et al found that although ED 
was perceived as an important loss in a person’s life, some 
people learned to cope with it, rather than seek help.17 Older 
men attributed a reduction in their sexual capacity and 
impaired erectile functionality to ageing. They conditioned 
themselves to accept it.13 
Our opinion is that doctors need to regularly enquire about 
sexual functionality, and screen patients by using the IIEF-
5 to detect the presence of ED. Another equally important 
issue that should be addressed is physicians’ reluctance 
to address these issues, and treat patients with ED. From 
the literature, it can be noted that most Malaysian general 
practitioners assume a passive role when diagnosing or 
managing the problem, and only discuss it if the patient 
raises the topic.18 These socio-cultural factors affect both 
the patient and his doctor, and may account for the low 
prevalence of perceived ED in our study population. 
The rationale for offering treatment to a patient who 
perceives that he does not have ED may be questioned. 
However, we are of the opinion that engaging in a discussion 
about ED may resolve fears and encourage discussion in 
patients who do not have the courage to ask their physicians 
about ED. The final decision on whether or not to treat the 
patient would depend on the impact of the condition on 
the patient’s life and sexual relationship, as well as what is 
agreed between the patient and his physician.
In our study, the prevalence of ED among hypertensive 
patients was similar to that found in studies carried out by 
Burchardt et al in the USA, which showed the prevalence 
of ED to be 68.3% among hypertensive outpatients.19 A 
similar study by Giuliano et al observed an ED prevalence 
of 67% among patients with hypertension, diabetes or 
both conditions.20 However, studies by Doumas et al15 and 
Jensen et al21 found a lower prevalence of ED, 35.2% and 
26.7% respectively, among hypertensive patients. The 
available literature suggests that ED is strongly associated 
with hypertension.
There are several mechanisms that explain the pathogenesis 
of ED in hypertensive patients. ED can be considered to be a 
symptom of vascular endothelium damage.22 The synthesis 
of nitric oxide is necessary for smooth muscle relaxation 
to occur, causing a rise in blood flow, and resulting in an 
erection. Severe hypertension is associated with endothelial 
dysfunction and reduced nitric oxide production by the 
endothelium.23 However, in our cohort, we noted that 
hypertension control was not related to ED. The mean 
blood pressure of the cohort, as well as the proportion of 
patients achieving treatment targets, may account for the 
weak association between ED and blood pressure control 
(p-value = 0.398, p-value = 0.377).
Medical practitioners do not hesitate to discontinue or 
change antihypertensive agents when newly diagnosed 
hypertensive patients present with ED symptoms.15 Feldman 
et al pointed out that 25% of ED cases related to the adverse 
effects to medication, and antihypertensive drugs are the 
most implicated class.3 Our study did not demonstrate 
Table V: ED and age
Age (years) n (%) IIEF-5 mean 
±SD
p-value
30-40 9 (4.5) 20.22 ± 3.35 0.0001
41-50 25 (12.5) 18.16 ± 6.79
51-60 77 (38.5) 15.81 ± 8.33
61-70 73 (36.5) 12.29 ± 9.06
> 70 16 (8.0) 6.13 ± 7.31








(% within  
medication group) p-value
1 51 (67.1) 25 (32.9)  0.881
2 57 (30.5) 25 (30.5) (χ2 = 0.253, 
3 or more 30 (71.4) 12 (28.6) df = 2)
Total 138 (69.0) 62
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an association between ED and antihypertensive drugs, 
and this is similar to the findings of the Treatment in Mild 
Hypertension Study (TOHMS), which reported that long-
term ED sequelae were not associated with antihypertensive 
treatment.24
Almost all types of antihypertensive agents have been 
implicated as a cause of ED. Studies such as the Trial of 
Antihypertensive Interventions and Management (TAIM)25 
and TOMHS24 have provided data on the effects of thiazide 
diuretics and beta blockers, which worsen ED. However, 
our findings did not demonstrate an association between 
ED and beta blockers or thiazides. The absence of beta-
blocker influence on ED concurs with the review paper 
by Ko et al, which concluded that there was a lack of 
substantial evidence of sexual dysfunction with beta-
blocker use.26 Similarly, our study was not able to detect 
any other antihypertensive groups that may have had an 
influence on ED. It is our suggestion that the presence 
of ED in hypertensive patients should not be attributed 
immediately to any antihypertensive medications. All other 
organic or non-organic causes should be considered.
Current literature highlights the increasing awareness 
of the high prevalence of ED among men with coronary 
artery disease. This is due to the fact that LDL cholesterol 
production causes the destruction of endogenous nitric 
oxide synthetase (NOS), resulting in endothelium vascular 
damage and subsequent ED.27 Post hoc analysis of our 
study population did not show any association between 
ED and LDL cholesterol. This is similar to a study among 
Turkish patients that did not detect any association between 
ED and dyslipidaemia or hypercholesterolaemia.28 On the 
other hand, a case-control study carried out by Nikoobakht 
et al found that total cholesterol and LDL cholesterol levels 
showed a negative correlation with IIEF scores.29 However, 
we acknowledge the fact that the well-controlled lipid levels 
in our population could have resulted from the use of lipid-
lowering agents, such as statins or fibrates, or both, which 
have been known to affect steroid hormone synthesis.30 
This suggests that dyslipidaemia or hypercholesterolaemia 
per se are not risk factors for ED.
Smoking has been identified as a risk factor for many 
prevalence-type studies. Our study suggests that smoking 
is not associated with the prevalence of ED. However, the 
Massachusetts Male Ageing Study showed that cigarette 
smoking did not have an effect on the incidence of ED,31 but 
doubled the risk for developing ED in patients without any 
cardiovascular risk factors.32 
A moderate, negative correlation was found to exist 
between ED and patients’ age. Elderly persons had lower 
erectile functionality as scored by the IIEF-5 (r = -0.367, 
p-value > 0.05). The finding was consistent with other major 
population studies which reported that the prevalence of 
ED increased with age.5-7 However, in recent years, there 
seems to have been a momentous shift in how men view 
sexual activity. As the ageing population increases around 
the world, better health and quality of life issues have been 
highlighted in the media. This includes interest in sexual 
behaviour and sexual problems in the middle-aged and 
elderly populations. Contrary to the popular belief that 
sexual activity reduces with ageing, many studies have 
proven that sexual interest and activity persist in these age 
groups.13,33 
In terms of seeking treatment for ED, our cohort preferred 
the use of traditional remedies for ED, as these were easily 
available in the local setting. Traditional remedies are often 
marketed as “health supplements”, and can be purchased 
easily without a prescription, which would avoid unnecessary 
embarrassment. The choice of traditional remedies for ED 
among our patients contrasted with findings of the Asian 
Men’s Attitudes to Life Events and Sexuality (MALES) study, 
which reported that the Malaysian population preferred 
to take modern medications.6 However, the Asian MALES 
study was a population-based study, and did not focus on 
hypertensive patients who were already taking medication 
for their condition. Despite this, the majority of our patients 
(62.9% for perceived ED, 67.3% for proven ED) did not 
seek any treatment for their ED, and this concurs with 
the findings of the Asian MALES Study.6 Further research 
exploring the reasons why hypertensive patients choose to 
take traditional medicines to treat ED, needs to be carried 
out.
We propose that longitudinal studies be carried out in 
hypertensive men who develop ED while undergoing 
treatment, and to more closely examine the risk factors 
and treatment-seeking behaviour of hypertensive patients 
with ED. We also recommend that doctors should routinely 
enquire about ED, and use the IIEF-5 to diagnose it, 
since this study has found that there is a significant 
difference between patients’ perceptions and actual 
erectile functionality. Recording the history leading to the 
development of ED should be as important as monitoring 
vital signs during a routine clinical visit. Any report of ED as 
a side effect of antihypertensive medications should prompt 
the doctor to investigate further before attributing it to the 
medication alone.
Conclusion
ED was found to be highly prevalent among hypertensive 
patients. Patients were willing to discuss ED if the physicians 
initiated the discussion. The majority of patients with either 
perceived ED, or those with confirmed ED, used traditional 
remedies to rectify the problem. ED was associated with 
age, but not with hypertension duration and control, use 
of antihypertensive medication, hypercholesterolaemia or 
smoking.
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